|
Category: Cancer (Oncology),
|
HIC#14354
|
| Title: |
A PHASE III TRIAL OF PELVIC RADIATION THERAPY VERSUS VAGINAL CUFF BRACHYTHERAPY FOLLOWED BY PACLITAXEL/CARBOPLATIN IN PATIENTS WITH HIGH-RISK, EARLY STAGE ENDOMETRIAL CANCER
|
|
Contact:Heather Lothamer
Phone:(434)243-0315
E-mail:hll5y@virginia.edu
UVa Health System, the Department of Obstetrics and Gynecology, the division of Gynecologic Oncology, seeks Women ages 18 and above with high-risk early stage endometrial cancer for research study.
The purpose of the study is to compare the effects of radiation therapy to the pelvis with vaginal radiation therapy combined with 3 cycles of the chemotherapy drugs paclitaxel and carboplatin on you and your high-risk Stage I-II endometrial cancer to find out which works better in reducing the chance that your cancer comes back. The pelvic radiation therapy (Regimen I) is considered standard of care. In addition, this study will compare survival, side effects, and differences in where the cancer may recur in patients treated with one of the two treatments. The study will also look at how a patient's overall health and weight impact how well patients do and how these factors affect a patient's quality
of life. This study is also interested in testing samples of your tumor tissue (if available form a previous surgery) and blood to determine if this testing can be used in the future to determine which patients may respond to treatment or have a good prognosis.
ยง No compensation is provided for this study.
Contact Information:
For more information please contact:
" Heather Lothamer, MSN
" 434-924-2745 or HLL5y@virginia.edu
" IRB-HSR #14354
Principal Investigator: Susan Modesitt, MD
|
|
|
 Primary Investigator: Modesitt Susan, C
Department: Obstetrics & Gynecology
|
Accepts adult enrollment :NO
Accepts minor enrollment :NO |